SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancersGreg G. Jones(London Cancer), Pablo Rodriguez‐Viciana(University College London)Nature CommunicationsJune 10, 201910.1038/s41467-019-10367-xCited by 82SaveCiteExport RISWatch citationsRelated PapersPIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation|Cancer Research|2008|193